Deep Dive: Page 4
Industry insights from our journalists
-
Private equity sees ripe opportunity in healthcare this year
Potential targets include orthopaedics, gastroenterology and urology practices and mental health and addiction services, analysts say.
Samantha Liss • March 25, 2019 -
As 5G looms, most hospitals watch from the sidelines
Chicago's Rush is an early mover with the tech, but many other big systems are taking a wait-and-see approach.
Rebecca Pifer • March 21, 2019 -
Yujin Kim
Mixing medicine and money: Why the rise of health system VCs is raising ethical concerns
More dollars than ever are flowing from VCs affiliated with nonprofit health systems, spurring questions around conflicts of interest.
Taylor McKnight • March 4, 2019 -
Getty Images
Neuromodulation market expands amid hunt for opioid alternatives
Stigma, cost and risk of surgery don't seem to be stopping growth of devices that target nerve activity central to diseases like Alzheimer's, epilepsy and chronic pain.
Meg Bryant • Feb. 22, 2019 -
Oscar & Associates for HIMSS
4 main takeaways from HIMSS19
Digest the biggest health IT conference of the year with this roundup of what grabbed the attention of more than 43,000 health execs, policymakers and academics.
David Lim and Rebecca Pifer • Feb. 15, 2019 -
HIMSS19: Private sector catch-up, patient matching and standard APIs dominate first full day
Support for the HHS rules (but some concern over implementation) was the focus at the start of health IT's biggest week.
Rebecca Pifer • Feb. 13, 2019 -
CMS eases study parameters in depression device coverage decision
LivaNova seeks to enroll clinical trial patients beginning in the third quarter of 2019. Those patients will only need to demonstrate response rather than remission, per CMS updates to the finalized decision memo.
Maria Rachal • Updated Feb. 19, 2019 -
Clinical lab lobbying spikes as PAMA cuts kick into effect
Paralleling CMS payment cuts that took effect at the start of last year, lobbying by Quest Diagnostics, LabCorp and the American Clinical Laboratory Association jumped to $4.4 million, up from $2.5 million in 2017.
David Lim • Feb. 1, 2019 -
Why home health tech is capturing investment in 2019
Startups and established providers alike are looking at the potential for devices and technology to help patients manage and receive their treatments from the comfort of home.
Meg Bryant • Jan. 28, 2019 -
HIMSS
HIMSS19: 5 panels you don't want to miss
The healthcare world is buzzing about what to expect at the biggest IT conference of the year. Here are five key panels you should plan to attend.
David Lim and Rebecca Pifer • Jan. 28, 2019 -
Danielle Ternes
How AI could shape the health tech landscape in 2019
Highlights include technologies that cut costs and promote patient health, especially in the areas of imaging, diagnostics, predictive analytics and administration.
Rebecca Pifer • Jan. 10, 2019 -
Getty
What's in a connected medical device? Cybersecurity regulators want to know
FDA could require device makers to publicize a software bill of materials as early as the premarket application process to more quickly identify vulnerabilities in the event of a cyberattack.
Meg Bryant • Jan. 3, 2019 -
Brian Tucker
Why political contributions linked to a little-known hearing aid firm topped medtech giants
Spending connected to Starkey Hearing Technologies surpassed Medtronic, Boston Scientific and Edwards Lifesciences during the 2018 election cycle.
David Lim • Nov. 29, 2018 -
3D printing poised to disrupt healthcare
Health industry types are "100% convinced, and rightly so, that [3D printing] will be a core part of their business in five to 10 years," ISG's Michael Harmon said.
Meg Bryant • Nov. 12, 2018 -
Red states say 'yes' to Medicaid; DME gets boost in Nevada
Three GOP-heavy states expanded Medicaid on Tuesday, and Democratic governor pickups in other parts of the country could further the trend. Elsewhere, durable medical equipment makers scored a win in Nevada.
Rebecca Pifer • Nov. 7, 2018 -
Parker Johnson on Unsplash
Midterms 2018: Key health ballot votes in the states
It's not just Congress up for grabs in Tuesday's midterm elections. From Medicaid expansion to dialysis treatments to nurse staffing ratios, here's a snapshot of key votes, the odds and what they could mean for the industry.
David Lim, Tony Abraham, Rebecca Pifer and Samantha Liss • Nov. 2, 2018 -
5 sticking points in the EU medical device reg transition
Brexit and notified body capacity are among the uncertainties, as many in the medtech sector are uninformed.
Meg Bryant • Oct. 29, 2018 -
Fotolia
FDA takes aim at lack of pediatric devices
"Funding is a huge challenge because of the inherently small market," Reed McCarty, co-founder and partner at SandBox Medical, told MedTech Dive.
Meg Bryant • Oct. 8, 2018 -
Getty Images
FDA rarely uses its power to recall dangerous medical devices. Why not?
"Once products are on the market, it's almost an insurmountable threshold to get the agency to take action to pull them from the market," Public Citizen's Michael Carome said.
Meg Bryant • Aug. 31, 2018 -
Yujin Kim, Industry Dive
Blockchain in healthcare: Huge promise, but largely unproven
"What blockchain has been able to do is create markets where a market didn't previously exist," according to Noah Zimmerman, director of Mount Sinai's Center for Biomedical Blockchain Research.
Meg Bryant • Aug. 30, 2018 -
LDT legislation gains allies, moves closer to finish line
At the same time, FDA comments on the bill drew the ire of the clinical lab sector.
David Lim • Aug. 21, 2018 -
Medical device industry caught in US-China trade war
"If this keeps escalating … a tit-for-tat game without any end in sight, that's very concerning to our industry and ultimately to patient care," a top industry imaging official said.
Meg Bryant • Aug. 13, 2018 -
Getty
Industry balks at FDA's cybersecurity plans
"We already know that FDA will reject premarket submissions if they do not follow the cybersecurity guidance," AdvaMed's Zach Rothstein said.
Meg Bryant • Aug. 1, 2018 -
Credit: Getty / Edited by BioPharma Dive
Payers, doctors weigh AI's disruptive prescribing potential
The disruption won't happen overnight, though, as big tech firms try to not only develop healthcare AI tools, but show they'll enhance, rather than upend, the doctor-patient relationship.
Jacob Bell • July 23, 2018 -
Pharma and AI? Let's try augmented intelligence first
Pharma will need collaborations and in-house capabilities to successfully use AI across drug development.
Lisa LaMotta • July 23, 2018
Previous
